Eli Lilly (LLY) vs Roche (ROG)
Eli Lilly (LLY) and Roche (ROG) side by side: both in Healthcare, listed on New York Stock Exchange and SIX Swiss Exchange. Eli Lilly is the larger of the two by approximate market capitalization (about 3.0×).
| Field | Eli Lilly | Roche |
|---|---|---|
| Legal name | Eli Lilly and Company | Roche Holding AG |
| Ticker | LLY | ROG |
| Exchange | New York Stock Exchange XNYS | SIX Swiss Exchange XSWX |
| Jurisdiction | United States | Switzerland |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals and diagnostics |
| Market cap ≈ | $1.1tn | $368.3bn |
| Founded | 1876 | 1896 |
| Reporting currency | USD | CHF |
| LEI | FRDRIPF3EKNDJ2CQJL29 | 549300U41AUUVOAAOB37 |
| ISIN | US5324571083 | CH0012032048 |
| FIGI | BBG001S5STL8 | BBG001SD12S2 |
| Index membership | S&P 500 | — |
| Held by (covered funds) | 1 | — |
Eli Lilly
Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.
Roche
Basel-based healthcare group founded in 1896, the world leader in in-vitro diagnostics and a top oncology drugmaker. The founding Hoffmann and Oeri families still hold a controlling voting stake.
Market caps are computed from each issuer's own filed share count times the close on 2026-08-28, not copied from a vendor; LEI from GLEIF (CC0), ISIN read from each issuer's own primary listing document with its ISO 6166 check digit validated, FIGI from OpenFIGI, MIC from the ISO 10383 registry — full provenance on Sources. Not real-time, not investment advice. Both sides as data: /api/v1/companies/eli-lilly · /api/v1/companies/roche